Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127888161 | 12788816 | 1 | I | 20160915 | 20160928 | 20160928 | EXP | PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-124369 | RANBAXY | SZYMANSKA-GARBACZ E, CZUPRYNIAK L. PROBLEMS IN THE TREATMENT OF DIABETES - PART 21; DIABETIC NEPHROPATHY - THE DEVIL IS NOT SO TERRIBLE ANYMORE. MED PRAKT. 2016;6:94-98 | 0.00 | M | Y | 0.00000 | 20160928 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127888161 | 12788816 | 1 | SS | ENALAPRIL | ENALAPRIL | 1 | Unknown | 10 MG, BID | N | 0 | 10 | MG | Q12H | ||||||
| 127888161 | 12788816 | 2 | PS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | 80 MG, TID | N | 71489 | 80 | MG | Q8H | ||||||
| 127888161 | 12788816 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | Unknown | 10 MG, QD | U | 0 | 10 | MG | |||||||
| 127888161 | 12788816 | 4 | C | Insulin | INSULIN NOS | 1 | Unknown | U | 0 | ||||||||||
| 127888161 | 12788816 | 5 | C | Insulin Mixture 30/70 | 2 | Unknown | 20 U, BID | U | 0 | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127888161 | 12788816 | 1 | Product used for unknown indication |
| 127888161 | 12788816 | 2 | Product used for unknown indication |
| 127888161 | 12788816 | 3 | Product used for unknown indication |
| 127888161 | 12788816 | 4 | Product used for unknown indication |
| 127888161 | 12788816 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127888161 | 12788816 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127888161 | 12788816 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127888161 | 12788816 | 1 | 1998 | 0 | ||
| 127888161 | 12788816 | 2 | 1998 | 0 | ||
| 127888161 | 12788816 | 3 | 1998 | 0 | ||
| 127888161 | 12788816 | 5 | 2002 | 0 |